ELOCTATE 1000

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

COAGULATION FACTOR VIII

Mevcut itibaren:

SANOFI - AVENTIS ISRAEL LTD

ATC kodu:

B02BD05

Farmasötik formu:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Kompozisyon:

COAGULATION FACTOR VIII 1000 IU

Uygulama yolu:

I.V

Reçete türü:

Required

Tarafından üretildi:

BIOGEN IDEC LIMITED , UK

Terapötik alanı:

COAGULATION FACTOR VII

Terapötik endikasyonlar:

ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.

Yetkilendirme tarihi:

2017-01-09